Before new interventions can be used in disease control programmes, it is essential that they are carefully evaluated in \u201cfield trials\u201d, which may be complex and expensive undertakings. Descriptions of the detailed procedures and methods used in trials that have been conducted in the past have generally not been published. As a consequence, those planning such trials have few guidelines available and little access to previously accumulated knowledge. In this book the practical issues of trial design and conduct are discussed fully and in sufficient detail for the text to be used as a \u201ctoolbox\u201d by field investigators. The toolbox has now been extensively tested through use of the first two editions and this third edition is a comprehensive revision, incorporating the many developments that have taken place with respect to trials since 1996 and involving more than 30 contributors. Most of the chapters have been extensively revised and 7 new chapters have been added.<\/p>\n
directed against disease problems in low- and middle-income countries<\/a> (LMICs). Our main emphasis is on randomized controlled trials<\/a> (RCTs), but many of the issues discussed are of relevance to other kinds of field research in LMICs. Published papers reporting the results of intervention trials rarely include details of the practical aspects of preparation for a trial and its conduct, yet these are crucial to the execution of a successful trial. Those conducting trials for the first time often do not have access to references detailing the many practical issues that have to be addressed in the organization and conduct of a trial. New investigators generally have to learn by experience and, as a consequence, often repeat mistakes that others have learned not to make. While \u2018learning by doing\u2019 can be a valuable educational method, it is usually inefficient and wasteful. We have tried to synthesize the experience of investigators with substantial experience of conducting field trials in LMICs and describe procedures and practices found to work well in LMIC settings. Thereby, we hope that new investigators will build on and extend the experience of others, rather than repeat the same mistakes.<\/p>\n Trials of health interventions involve the implementation of a specific health intervention and comparison of the effects of that intervention with the effects of the currently available \u2018best\u2019 intervention or, if there is none, comparison with what happens with no intervention (or with a placebo). In order to avoid bias in the allocation of participants to the intervention or comparison group, assignment of individuals or groups to a particular intervention should be done by randomization. The \u2018trial\u2019 approach is in contrast to observational studies such as cross-sectional surveys, cohort studies, and case-control studies. But many of the methods and techniques described in this book may also be usefully deployed in observational studies.<\/p>\n We use the term \u2018field trial\u2019 for trials conducted outside clinical settings, in contrast to \u2018clinical trial\u2019 that is used for studies carried out in health facilities. Thus, field trials generally involve participants who are living at home in their normal environment, rather than being \u2018captive\u2019 in hospitals or outpatient clinics. Most trials of preventive measures, such as immunizations or health education, are \u2018field\u2019 trials. Important differences in field and clinical trials<\/a> include inclusion and exclusion criteria that may be less stringent in field trials than criteria often imposed in clinical trials, in which it may be important to have a clearly defined disease condition for treatment. To the extent that there are less stringent inclusion and exclusion criteria, there may be fewer problems with the external validity of trial conclusions than there often are for clinical trials that limit the generalizability of conclusions. Another difference is that randomization of intervention by groups (clusters), rather than by individuals, is more often necessary or useful in field trials than in clinical trials.<\/p>\n","protected":false},"excerpt":{"rendered":"